Scroll
Cells in the Dish Should Resemble Cells in the Body.
NanoSurface Biomedical provides innovative products and services for drug development, disease modeling, and fundamental research into cell biology. NanoSurface technology imitates the native extracellular matrix and structures cultured cells into physiologically relevant models.
(CDI iCell) Conventional Dish
(CDI iCell) NanoSurface Cultureware
Native Human Heart
Human iPSC-derived cardiomyocytes cultured in a NanoSurface dish develop structural and functional phenotypes similar to native cardiac tissue. NanoSurface culture is consistent, reproducible, and fast, which is why many scientists rely on NanoSurface technology as a new standard for iPSC-derived cardiomyocyte culture.
More Mature Phenotypes
Recreate the native microenvironment of the cell with structural cues.
Develop more physiologically relevant structure and function.
Informational Videos
Recent News
News & Blog
Come to our talk (lunch provided!) at World Pharma Week 2019, “Structural Maturation in the Development of hiPSC-Cardiomyocyte Models for Pre-clinical Safety, Efficacy, and Discovery” on Wed, 6/19 at Noon.
The NanoSurface eCyte 6, an electrical stimulation system for excitable cells in vitro, has been featured in Science, the premier global science weekly published by AAAS. You can find it in the 'New Products' section of this week’s issue (24 May 2019, Vol 364, Issue 6442, pp. 794).
Members of the 4th Industrial Revolution committee from the National Assembly of the Republic of Korea visited NanoSurface Biomedical on May 17, 2019 to learn how the Greater Seattle Area is advancing in STEM and innovation. The National Assembly delegation visited leading Seattle-based companies including Amazon, Boeing, Microsoft, and NanoSurface Biomedical.
Come stop by our poster presentation #B273, on Sunday, April 7th between 10 AM - 12 PM EST to learn more about “Enhancing pre-clinical in vitro cardiotoxicity assays with bioengineering strategies in a high-throughput manner.”
Visit Booth 845 to discuss how NanoSurface products can help you produce more physiologically relevant data!
NanoSurface Biomedical announced today the launch of the NanoSurface Car(ina)™ platform for highly predictive pre-clinical drug screening, using structurally matured human induced pluripotent stem cell (iPSC) derived heart tissues.
Dr. Nicholas Geisse and Dr. Alec Smith will be giving a technical talk at SOT 2019 titled, “Biomimetic Culture Environments to Enhance In Vitro Assays.” Come attend the talk on Wednesday, March 13, 2019 at 1:30 PM, in Room 338.
The NanoSurface team will be in Baltimore, MD, March 3-5 for Biophysical Society 2019!
Dr. Ghazizadeh, our Applications Scientist, will be giving a technical talk on "Biomimetic Cell Culture Platforms for Enhancing Cell Biology Studies" on Monday, March 4th, 3:30 PM at Room 303.
Meet us at Booth 505 and learn how mimicking structural (nanotopography), mechanical, and electrochemical cues of the Extracellular Matrix can help you produce more physiologically relevant data.
The NanoSurface team is at Washington D.C. for SLAS 2019! Come by Booth 1648 during exhibiting hours from February 4 - 6.
We are very excited to announce our latest distribution partnership with MatTek Corporation, a leader in the life sciences industry!
We’re in Los Angeles, CA for the International Society for Stem Cell Research 2019! Visit us at Booth 323 to learn how nanotopography and our biomimetic technologies can accelerate your stem cell research!